Cell Culture Media Bags Market Research Report Information by Product Type (Single-use Bags, Reusable Bags, Customizable Bags), by Material (Polyethylene, Polypropylene, Ethylene Vinyl Acetate (EVA), Others), by Capacity (Small-sized Bags, Medium-sized Bags, Large-sized Bags), by Application (Monoclonal Antibody Production, Vaccine Production, Cell Therapy, Stem Cell Research, Others), by End-User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutions, Others) and Region (North America, Europe, Asia-Pacific, Rest of

Cell Culture Media Bags Market Overview

The Cell Culture Media Bags Market was valued at USD 1.37 Billion in 2024. The Cell Culture Media Bags Market industry is projected to grow from USD 1.51 Billion in 2025 to USD 3.79 Billion by 2035, exhibiting a compound annual growth rate (CAGR) of 10.15% during the forecast period (2025-2035).

The growing investment in the field of gene therapy and frequent infectious disease outbreaks and increasing incidences of chronic diseases are driving the growth of the Cell Culture Media Bags Market.

As per the Analyst at MRFR, the growing investment in the field of gene therapy is significantly boosting the expansion of the global cell culture media bag market. As gene therapy progresses, the demand for advanced biomanufacturing solutions, including high-quality cell culture media and associated equipment, is rising. Gene therapies often require large-scale production of viral vectors and cell-based products, which are cultivated in specialized media bags for optimal growth and genetic modification of cells.

FIGURE 1: CELL CULTURE MEDIA BAGS MARKET VALUE (2019-2035) USD BILLION

 Source: Secondary Research, Primary Research, MRFR Database, and Analyst Review

Cell Culture Media Bags Market Opportunity

CELL CULTURE MEDIA ASSOCIATED INVESTMENT

The growing focus on cell culture media associated investment is creating abundant opportunities for the global cell culture media bag market, as an increasing number of biotechnology and pharmaceutical companies are investing in advanced cell culture technologies. These investments are primarily driven by the rising demand for biopharmaceuticals, cell-based therapies, and personalized medicine, which require highly specialized and scalable cell culture systems. For instance,

• July 2024: Merck has invested USD 6.85 million to expand its cell culture media (CCM) production at its Nantong site in China, establishing a GMP-compliant manufacturing line. This expansion will support local biopharma manufacturers by meeting the growing demand for novel medicines, vaccines, and therapeutics. The investment enables a smooth transition from pilot to commercial scale, accelerating time-to-market for life-saving therapies. By localizing production, Merck ensures Chinese customers have reliable access to its high-quality custom CCM products, enhancing process efficiency and consistency through Merck’s expert formulation capabilities. This move strengthens Merck’s commitment to supporting biopharmaceutical innovation in China.


• July 2023: Merck KGaA (Germany) announced a USD 23.88 million investment to expand its Lenexa, Kansas facility, making it the company's largest dry powder cell culture media production site and a Center of Excellence (COE) in North America. The expansion adds 9,100 square meters of manufacturing and lab space, boosting Merck's capacity to meet increasing demand for biopharmaceuticals and biotech products. This investment is expected to create 60 new jobs in the Kansas City area, further strengthening Merck's position in the global cell culture media market.


• November 2022: Fujifilm Corporation (Japan) invested USD 188 million in cell culture media manufacturing facilities to fulfil the needs of its customers in the biopharmaceutical industry.


• November 2019: Thermo Fisher Scientific, Inc. (US) invested more than USD 250 million in its US, Europe, India, Argentina, and China operations to boost the production of its cell culture media.

As companies expand their research and manufacturing capabilities, the need for efficient, cost-effective, and contamination-free solutions, like single-use media bags, has surged. Cell culture media bags are integral to maintaining sterile environments, supporting cell growth, and ensuring the purity of biologics during production. This expanding sector has attracted substantial funding from both private and public investors, fostering innovations in cell culture media formulations and bioprocessing technologies, thus accelerating the adoption of cell culture media bags across various applications. Additionally, these investments are helping to drive advancements in the customization of media bags for specialized cell types and bioreactor systems, ensuring that the market continues to flourish as the demand for biologics and regenerative therapies grows globally.

Cell Culture Media Bags Market Segment Insights

Cell Culture Media Bags by Product Type Insights

Based on Product Type, this segment includes Single-use Bags, Reusable Bags, Customizable Bags. The Single-use Bags segment dominated the global market in 2024, while it is projected to be the fastest–growing segment during the forecast period. Single-use bags are a critical component of the cell culture media bags market, offering a versatile, cost-effective, and sterile solution for various biomanufacturing and laboratory applications. 

These bags are primarily used for the preparation, storage, and handling of cell culture media used in the growth and maintenance of cells in research and production environments, including in the biopharmaceutical, biotechnology, and academic sectors. The single-use (or disposable) nature of these bags aligns with the growing trend of single-use technology in bioprocessing to increase efficiency, reduce costs, and improve safety.

FIGURE 2: CELL CULTURE MEDIA BAGS MARKET SHARE BY PRODUCT TYPE 2024 AND 2035 (USD BILLION)

Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

Cell Culture Media Bags by Material Insights

Based on Material, this segment includes Polyethylene, Polypropylene, Ethylene Vinyl Acetate (EVA), and Others. The Polyethylene segment dominated the global market in 2024, while the Ethylene Vinyl Acetate (EVA) segment is projected to be the fastest–growing segment during the forecast period. Cell culture media bags are critical components in the biopharmaceutical, biotechnology, and research industries, enabling efficient storage, mixing, and transportation of cell culture media.

The selection of materials for these bags is driven by the need for biocompatibility, chemical resistance, flexibility, and sterilization compatibility, ensuring optimal performance across a range of applications. Commonly used materials include polyethylene (PE) for its cost-effectiveness and moisture resistance, polypropylene (PP) for its heat resistance and durability, and ethylene vinyl acetate (EVA), which offers flexibility and is particularly suitable for cryopreservation.

Cell Culture Media Bags by Capacity Insights

Based on Capacity, this segment includes Small-sized Bags, Medium-sized Bags, Large-sized Bags. The Medium-sized Bags segment dominated the global market in 2024, while the Small-sized Bags segment is projected to be the fastest–growing segment during the forecast period. Medium-sized bags, with capacities ranging from 5 L to 20 L, dominate pilot-scale production and mid-scale bioprocessing due to their versatility and balance between capacity and handling convenience.

Cell Culture Media Bags by Application Insights

Based on Application, this segment includes Monoclonal Antibody Production, Vaccine Production, Cell Therapy, Stem Cell Research, Others. The Monoclonal Antibody Production segment dominated the global market in 2024, while the Vaccine Production segment is projected to be the fastest–growing segment during the forecast period. Cell culture media bags play a vital role in the production of monoclonal antibodies (mAbs), which are essential for treating a range of diseases, including cancer, autoimmune disorders, and infections. 

These bags are used to store, prepare, and transport the culture media necessary for the growth of mammalian cells, such as CHO cells, that produce the desired antibodies. The use of cell culture media bags in mAb production ensures a sterile, contamination-free environment, which is critical for maintaining the integrity of the production process. They also offer scalability, with bags available in various sizes to accommodate both small-scale research and large-scale commercial manufacturing. The single-use technology associated with these bags eliminates the need for cleaning and sterilization, reducing contamination risks and increasing efficiency.

Cell Culture Media Bags by End-User Insights

Based on End-User, this segment includes Pharmaceutical and Biotechnology Companies, Academic and Research Institutions, Others. The Pharmaceutical and Biotechnology Companies segment dominated the global market in 2024, while it is projected to be the fastest–growing segment during the forecast period. Cell culture media bags are a key enabler for pharmaceutical and biotechnology companies, offering a sterile, scalable, and cost-efficient solution for the production of biologics such as monoclonal antibodies, recombinant proteins, and vaccines. 

These bags ensure optimal conditions for cell growth by facilitating the storage, mixing, and transportation of culture media. With their single-use design, cell culture media bags minimize the risk of cross-contamination, reduce operational downtime, and eliminate the need for expensive cleaning and sterilization processes. They provide flexibility to scale production from research to commercial manufacturing, helping companies accelerate timelines and bring products to market faster. Additionally, these bags are compliant with regulatory standards, ensuring product quality and safety.

Cell Culture Media Bags Regional Insights

Based on the Region, the Global Cell Culture Media Bags are segmented into North America, Europe, Asia-Pacific, Middle East & Africa and Rest of the World. The North America dominated the global market in 2024, while the Asia-Pacific is projected to be the fastest–growing segment during the forecast period. Major demand factors driving the North America market are the growing investment in the field of gene therapy and frequent infectious disease outbreaks and increasing incidences of chronic diseases. He region also benefits from the presence of major industry players and supportive regulatory frameworks, which further drive market growth. 

However, the Asia-Pacific region is expected to be the fastest-growing segment during the forecast period. This rapid growth is attributed to increasing biopharmaceutical production, expanding healthcare infrastructure, and rising government investments in life sciences research. Additionally, growing awareness about cell-based therapies and the presence of a large patient population are fueling demand for cell culture media bags in emerging economies such as China and India. As a result, the Asia-Pacific region is becoming a key focus for market expansion and investment.

FIGURE 3: CELL CULTURE MEDIA BAGS MARKET VALUE BY REGION 2024 AND 2035 (USD BILLION)

Source: Secondary Research, Primary Research, MRFR Database, and Analyst Review

Further, the countries considered in the scope of the Application Tracking System Market are the US, Canada, EEA, Austria, Belgium, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Germany, France, UK, Italy, Spain, China, India, Japan, Australia, South Korea, Middle East, Africa, South America and others.

Global Cell Culture Media Bags Key Market Players & Competitive Insights

Many global, regional, and local vendors characterize the Cell Culture Media Bags Market. The market is highly competitive, with all the players competing to gain market share. Intense competition, rapid advances in technology, frequent changes in government policies, and environmental regulations are key factors that confront market growth. The vendors compete based on cost, product quality, reliability, and government regulations. Vendors must provide cost-efficient, high-quality products to survive and succeed in an intensely competitive market.

The major competitors in the market are Thermo Fisher Scientific Inc., Merck KGaA, Sartorius AG, Cytiva, OriGen Biomedical, Inc, Corning Incorporated, Lonza, Saint-Gobain Life Sciences, Fukoku Co. Ltd., Technoflex are among others. The Cell Culture Media Bags Market is a consolidated market due to increasing competition, acquisitions, mergers and other strategic market developments and decisions to improve operational effectiveness.

Key Companies in the Cell Culture Media Bags Market include

• Thermo Fisher Scientific Inc.


• Merck KGaA


• Sartorius AG


• Cytiva


• OriGen Biomedical, Inc


• Corning Incorporated


• Lonza


• Saint-Gobain Life Sciences


• Fukoku Co. Ltd.


• Technoflex

Cell Culture Media Bags Market Segmentation

Cell Culture Media Bags by Product Type Outlook

• Single-use Bags


• Reusable Bags


• Customizable Bags

Cell Culture Media Bags by Material Outlook

• Polyethylene


• Polypropylene


• Ethylene Vinyl Acetate (EVA)


• Others

Cell Culture Media Bags by Capacity Outlook

• Small-sized Bags


• Medium-sized Bags


• Large-sized Bags

Cell Culture Media Bags by Application Outlook

• Monoclonal Antibody Production


• Vaccine Production


• Cell Therapy


• Stem Cell Research


• Others

Cell Culture Media Bags by End-User Outlook

• Pharmaceutical and Biotechnology Companies


• Academic and Research Institutions


• Others

Cell Culture Media Bags Regional Outlook

• North America
  
  
  
  • US
  
  
  • Canada
  
  
  
  


• Europe
  
  
  
  • EEA
    
    
    
    • Austria
    
    
    • Belgium
    
    
    • Bulgaria
    
    
    • Croatia
    
    
    • Cyprus
    
    
    • Czech Republic
    
    
    • Denmark
    
    
    • Rest of EEA
    
    
    
    
  
  
  • Germany
  
  
  • France
  
  
  • UK
  
  
  • Italy
  
  
  • Spain
  
  
  • Rest of Europe
  
  
  
  


• Asia-Pacific
  
  
  
  • China
  
  
  • India
  
  
  • Japan
  
  
  • Australia
  
  
  • South Korea
  
  
  • Rest of Asia-Pacific
  
  
  
  


• Rest of the World
  
  
  
  • Middle East
  
  
  • Africa
  
  
  • South America
  
  
  
  

Report Attribute/Metric	Details
Market Size 2024	USD 1.37 Billion
Market Size 2025	USD 1.51 Billion
Market Size 2035	USD 3.79 Billion
Compound Annual Growth Rate (CAGR)	10.15% (2025-2035)
Base Year	2024
Forecast Period	2025-2035
Historical Data	2019-2023
Forecast Units	Value (USD Billion)
Report Coverage	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Segments Covered	By Product Type, By Material, By Capacity, By Application, By End-User
Geographies Covered	North America, Europe, Asia Pacific and Rest of the World
Countries Covered	The US, Canada, EEA, Austria, Belgium, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Germany, France, UK, Italy, Spain, China, India, Japan, Australia, South Korea, Middle East, Africa, South America
Key Companies Profiled	Thermo Fisher Scientific Inc., Merck KGaA, Sartorius AG, Cytiva, OriGen Biomedical, Inc, Corning Incorporated, Lonza, Saint-Gobain Life Sciences, Fukoku Co. Ltd., Technoflex
Key Market Opportunities	·         Cell culture media associated investment ·         Private and public organizations pharmaceutical R&D strategy
Key Market Dynamics	·         Growing investment in the field of gene therapy ·         Frequent infectious disease outbreaks ·         Increasing incidences of chronic diseases